Results 211 to 220 of about 27,626 (220)

Therapeutic Drug Monitoring of Voriconazole

Therapeutic Drug Monitoring, 2008
Voriconazole is a triazole antifungal developed for the treatment of life-threatening fungal infections in immunocompromised patients. The drug, which is available for both oral and intravenous administration, has broad-spectrum activity against pathogenic yeasts, dimorphic fungi, and opportunistic molds.
Bruggemann, R.J.M., Donnelly, J.P., Aarnoutse, R.E., Warris, A., Blijlevens, N.M.A., Mouton, J.W., Verweij, P.E., Burger, D.M.   +7 more
openaire   +4 more sources

Adverse Effects of Voriconazole

Orthopedics, 2004
Some medications are contraindicated with voriconazole because the interaction is too difficult to control or potential adverse effects are too dangerous.
openaire   +2 more sources

Voriconazole: A Novel Antifungal

Journal of Pharmacy Technology, 2003
Objective: To review the published in vitro, in vivo, and clinical data and FDA background documents that led to the approval of voriconazole. Data Sources: Articles were identified by the referenced package insert and by a MEDLINE search (1966–October 2002) using the terms voriconazole, azole antifungal, aspergillosis, and UK-109, 496.
Rupali Jain, Shana M. Gunderson, Larry H. Danziger   +2 more
openaire   +2 more sources

Plasma concentrations of voriconazole in falcons

Veterinary Record, 2007
Doses of 12·5 mg voriconazole/kg bodyweight administered every 12 hours by crop gavage to six falcons for 14 days provided peak plasma concentrations of more than 1 μg/ml, but the trough concentrations were lower and sometimes undetectable. Administering the same doses incorporated into meat that was fed to one falcon for seven days and to three ...
M.-E. Krautwald-Junghanns, A. Di Somma, F. R. Ungemach, F. Demiraj, Tom A. Bailey, Volker Schmidt   +5 more
openaire   +3 more sources

Voriconazol — Perspektiven und klinische Aspekte

Mycoses, 2002
Zusammenfassung. Der Wirkstoff von Vfend® ist Voriconazol, ein neues Antimykotikum aus der Gruppe der Triazole mit sehr breitem Wirkspektrum. Die Wirksamkeit wurde gegen Sproßpilz‐Arten wie Candida‐Species und Cryptococcus neoformans sowie gegen diverse Fadenpilze, insbesondere die Aspergillus‐Species, aber auch dimorphe Pilze in vitro und in vivo (in
openaire   +4 more sources

Synthesis of Voriconazole

Synfacts, 2014
openaire   +2 more sources

Voriconazole

2016
openaire   +1 more source

Voriconazole

2015
openaire   +1 more source

Bullous Phototoxicity from Voriconazole

The Journal of Emergency Medicine, 2014
David A. Wetter, Naiara S. Barbosa
openaire   +3 more sources

voriconazole

2009
Guillaume Chevrel, Virginie Dessus
openaire   +1 more source